Form EFFECT LEXICON PHARMACEUTICALS,
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | August 14, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lexicon drug shows cardiac and platelet effects in preclinical studies
- Atopic Dermatitis Pipeline Landscape 2026: Late-Stage Candidates, MOA Trends, and Routes of Administration by DelveInsight | GSk, Nestle SA, Pfizer, Regeneron, Abbvie, Allergan, Bausch Health Company
- Rheumatoid Arthritis Pipeline 2026: Key Companies, Clinical Trial Progress, and Mechanism of Action Insights by DelveInsight | Abbvie, Eli Lilly, Incyte, Taiho Pharma, Rise Therapeutics, Cyxone
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
